First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease

The combination of rifamycin (RFP), ethambutol (EB), and macrolides is currently the standard regimen for treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). However, poor adherence to the standardized regimens recommended by current guidelines have been reported. We undertook a sin...

Full description

Saved in:
Bibliographic Details
Published in:Sci Rep
Main Authors: Fukushima, Kiyoharu, Kitada, Seigo, Komukai, Sho, Kuge, Tomoki, Matsuki, Takanori, Kagawa, Hiroyuki, Tsujino, Kazuyuki, Miki, Mari, Miki, Keisuke, Kida, Hiroshi
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807086/
https://ncbi.nlm.nih.gov/pubmed/33441977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-81025-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items